title: [The effect of prolonged parenteral administration of liposomes and L-Dopa incorporated into liposomes on metabolism of dopamine and its metabolites in the striatum of mice with experimental parkinsonian syndrome].
authors.forename: V V
authors.initials: VV
authors.lastname: Iurasov
authors.forename: V G
authors.initials: VG
authors.lastname: Kucherianu
authors.forename: V S
authors.initials: VS
authors.lastname: Kudrin
authors.forename: I V
authors.initials: IV
authors.lastname: Zhigal'tsev
authors.forename: E V
authors.initials: EV
authors.lastname: Nikushkin
authors.forename: Iu G
authors.initials: IuG
authors.lastname: Sandalov
authors.forename: A P
authors.initials: AP
authors.lastname: Kaplun
authors.forename: V I
authors.initials: VI
authors.lastname: Shvets
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004337:Drug Carriers; D007274:Injections, Intraperitoneal; D007980:Levodopa / Q000008:administration & dosage*; D008081:Liposomes; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine